Ten year risk assessment of ischemic cardiovascular disease and intervention analysis among middle-aged residents with moderate risk and above in a Shanghai-based community

by Qi Xu, Jieyan Shen, Rong Shi, Hui Zhao
Published 2017-05-01

Effects of Fasudil on Patients with Pulmonary Hypertension Associated with Left Ventricular Heart Failure with Preserved Ejection Fraction: A Prospective Intervention Study

by Xiang Zhang, Xueming Zhang, Saihua Wang, Jun Luo, Zhihong Zhao, Changzhu Zheng, Jieyan Shen
Published 2018-01-01

Prevalence and Prognosis of Portopulmonary Hypertension in 223 Liver Transplant Recipients

by Jian Li, Qi Zhuang, Xueming Zhang, Ying Zheng, Zhiqing Qiao, Jianjun Zhang, Xuedong Shen, Jieyan Shen
Published 2018-01-01

MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways

by Zongye Cai, Jian Li, Qi Zhuang, Xueming Zhang, Ancai Yuan, Lan Shen, Kang Kang, Bo Qu, Yuanjia Tang, Jun Pu, Deming Gou, Jieyan Shen
Published 2018-04-01

Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors.

by Peng Nie, Dandan Li, Liuhua Hu, Shuxuan Jin, Ying Yu, Zhaohua Cai, Qin Shao, Jieyan Shen, Jing Yi, Hua Xiao, Linghong Shen, Ben He
Published 2014-01-01

Risk prediction in medically treated chronic thromboembolic pulmonary hypertension

by Ruilin Quan, Yuanhua Yang, Zhenwen Yang, Hongyan Tian, Shengqing Li, Jieyan Shen, Yingqun Ji, Gangcheng Zhang, Caojin Zhang, Guangyi Wang, Yuhao Liu, Zhaozhong Cheng, Zaixin Yu, Zhiyuan Song, Zeqi Zheng, Wei Cui, Yucheng Chen, Shuang Liu, Xiaoxi Chen, Yuling Qian, Changming Xiong, Guangliang Shan, Jianguo He
Published 2021-04-01